ArticleCurrent cancer drug targets2022

Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy.

Xue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.